Alveolus, Inc. Launches AERO(TM) Hybrid Tracheobronchial Stent System In U.S.

... Alveolus, Inc., a leading provider of non-vascular interventional stent technology, announced today the U.S. launch of its AERO(TM) Hybrid Tracheobronchial Stent System, which has been cleared by the U.S. Food and Drug Administration (FDA) for treatment of malignant pulmonary obstructions. Malignant pulmonary obstruction is the blockage of the airway or tracheobronchial tree. [click link for full article] ...